Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | PTC THERAPEUTICS, INC. | 7,423,970 | 9.8% | EDGAR |
SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | PTC THERAPEUTICS, INC. | 6,864,000 | 9.1% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | PTC THERAPEUTICS, INC. | 8,800,843 | 11.7% | EDGAR |
SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | PTC THERAPEUTICS, INC. | 9,816,603 | 13.0% | EDGAR |
SC 13G/A | 2024-01-24 | STATE STREET CORP | PTC THERAPEUTICS, INC. | - | 6.1% | EDGAR |
SC 13G/A | 2024-01-10 | FMR LLC | PTC THERAPEUTICS, INC. | 1,814,421 | 2.4% | EDGAR |
SC 13G/A | 2024-01-08 | BlackRock Inc. | PTC THERAPEUTICS, INC. | 7,668,871 | 10.2% | EDGAR |
SC 13G/A | 2023-11-13 | FMR LLC | PTC THERAPEUTICS, INC. | 6,431,850 | 8.5% | EDGAR |
SC 13G | 2023-10-30 | Camber Capital Management LP | PTC THERAPEUTICS, INC. | - | - | EDGAR |
SC 13D/A | 2023-06-15 | PTC THERAPEUTICS, INC. | ClearPoint Neuro, Inc. | 2,561,245 | 9.8% | EDGAR |
SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | PTC THERAPEUTICS, INC. | 5,615,387 | 7.7% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | PTC THERAPEUTICS, INC. | 10,782,306 | 15.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | PTC THERAPEUTICS, INC. | 7,339,520 | 10.2% | EDGAR |
SC 13G/A | 2023-02-09 | JANUS HENDERSON GROUP PLC | PTC THERAPEUTICS, INC. | 2,027,142 | 2.8% | EDGAR |
SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | PTC THERAPEUTICS, INC. | 7,430,907 | 10.3% | EDGAR |
SC 13G/A | 2023-02-01 | FRANKLIN RESOURCES INC | PTC THERAPEUTICS, INC. | 3,489,687 | 4.8% | EDGAR |
SC 13G/A | 2023-01-24 | BlackRock Inc. | PTC THERAPEUTICS, INC. | 6,640,854 | 9.2% | EDGAR |
SC 13G/A | 2022-07-11 | VANGUARD GROUP INC | PTC THERAPEUTICS, INC. | 7,183,692 | 10.1% | EDGAR |
SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | PTC THERAPEUTICS, INC. | 5,293,966 | 7.5% | EDGAR |
SC 13G | 2022-02-11 | HARTFORD MUTUAL FUNDS INC/CT | PTC THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |